ASP Isotopes Inc. Common Stock (ASPI) investor relations documents from the company's IR site: 5 presentations, 15 press releases; latest deck 2026-06-23. Read in-app with summaries. First-party data.
Company Presentation: ASP Isotopes is a developer of isotope enrichment technology targeting electronics, nuclear medicine, and energy, with a 2031 EBITDA target exceeding $300 million.
ASPI overview · ASPI earnings · ASPI financials · ASPI KPIs · ASPI ownership · ASPI peers · ASPI filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.